Nichols & Pratt Advisers LLP Biogen Inc. Transaction History

Nichols & Pratt Advisers LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$216.71 - $338.96 $152,130 - $237,949	-702 Closed	0 $0
Q2 2018 Jul 27, 2018	BUY	$257.52 - $306.91 $180,779 - $215,450	702 New	702 $204,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $182,611 - $258,272	-702 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $197,367 - $231,442	702	702 $220,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.